COMP <GO>
MAIR vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
Madison Air Solutions Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MAIR 4
— TMO 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: TMO
LAST: $23.16 (-5.70%) • MKT CAP: $12.32B
balance-sheet
1.71
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MAIR VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MAIR | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.60% | 9.30% | +4.30 | MAIR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.7x | 30.4x | -5.70 | MAIR | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 2.40% | -0.19 | TMO | /fcf-yield <GO> |
| Operating Margin | 13.90% | 17.40% | -3.50 | TMO | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 15.10% | -4.20 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 17.60% | 3.90% | +13.70 | MAIR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 1.71 | 4.50 | -2.79 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.70% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.8 | 59.1 | -16.32 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.94 | -0.01 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.6x | 36.3x | -8.70 | MAIR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.32B | $262.22B | -$249.90B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MAIR REV | TMO REV | MAIR GROSS % | TMO GROSS % | MAIR FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $44.56B | — | 44.0% | $0 | $6.29B |
| FY 2024 | — | $42.88B | — | 44.0% | — | $7.27B |
| FY 2023 | — | $42.86B | — | 44.0% | — | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MAIR // BETA 0.93
TMO // BETA 0.94